Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q389496> ?p ?o }
Showing triples 1 to 51 of
51
with 100 triples per page.
- Q389496 subject Q7403741.
- Q389496 abstract "Obinutuzumab (called afutuzumab until 2009, originally GA101) is a humanized monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in Europe, for the treatment of chronic lymphocytic leukemia in combination with chemotherapy in treatment-naive patients.".
- Q389496 atcPrefix "L01".
- Q389496 atcSuffix "XC15".
- Q389496 casNumber "949142-50-1".
- Q389496 fdaUniiCode "O43472U9X8".
- Q389496 wikiPageWikiLink Q1023650.
- Q389496 wikiPageWikiLink Q1072420.
- Q389496 wikiPageWikiLink Q1088156.
- Q389496 wikiPageWikiLink Q1138590.
- Q389496 wikiPageWikiLink Q11942.
- Q389496 wikiPageWikiLink Q128711.
- Q389496 wikiPageWikiLink Q14599311.
- Q389496 wikiPageWikiLink Q14906101.
- Q389496 wikiPageWikiLink Q159236.
- Q389496 wikiPageWikiLink Q1645075.
- Q389496 wikiPageWikiLink Q18029082.
- Q389496 wikiPageWikiLink Q188930.
- Q389496 wikiPageWikiLink Q19903200.
- Q389496 wikiPageWikiLink Q204711.
- Q389496 wikiPageWikiLink Q212646.
- Q389496 wikiPageWikiLink Q2626074.
- Q389496 wikiPageWikiLink Q332181.
- Q389496 wikiPageWikiLink Q334848.
- Q389496 wikiPageWikiLink Q3425168.
- Q389496 wikiPageWikiLink Q412323.
- Q389496 wikiPageWikiLink Q415939.
- Q389496 wikiPageWikiLink Q422248.
- Q389496 wikiPageWikiLink Q5029662.
- Q389496 wikiPageWikiLink Q585285.
- Q389496 wikiPageWikiLink Q5939625.
- Q389496 wikiPageWikiLink Q640448.
- Q389496 wikiPageWikiLink Q6750944.
- Q389496 wikiPageWikiLink Q6954118.
- Q389496 wikiPageWikiLink Q704930.
- Q389496 wikiPageWikiLink Q7403741.
- Q389496 wikiPageWikiLink Q845523.
- Q389496 wikiPageWikiLink Q864338.
- Q389496 wikiPageWikiLink Q898365.
- Q389496 wikiPageWikiLink Q974135.
- Q389496 atcPrefix "L01".
- Q389496 atcSuffix "XC15".
- Q389496 casNumber "949142".
- Q389496 unii "O43472U9X8".
- Q389496 type ChemicalSubstance.
- Q389496 type Drug.
- Q389496 type ChemicalObject.
- Q389496 type Thing.
- Q389496 type Q8386.
- Q389496 comment "Obinutuzumab (called afutuzumab until 2009, originally GA101) is a humanized monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in Europe, for the treatment of chronic lymphocytic leukemia in combination with chemotherapy in treatment-naive patients.".
- Q389496 label "Obinutuzumab".